Nonalcoholic fatty liver disease, also called metabolic dysfunction‐associated steatotic liver
disease, is the most common liver disease worldwide and has no approved …

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease, and is
related to fatal and non-fatal liver, metabolic, and cardiovascular complications. Its non …

Bile acid, the final product of cholesterol breakdown, functions as a complex regulator and
signaling factor in human metabolism. Chronic metabolic diseases pose significant medical …

Protein S deficiency (PSD) is an autosomal dominant disorder characterized by congenital
thrombophilia. Studies on PSD are limited yet, resulting in a lack of clarity about molecular …

HZMP-1 is a new polysaccharide isolated from Huang Zhen mycoplasm that contains seven
monosaccharides, and it has an average molecular weight of 16.817 kDa. Its structural …

Metabolic associated fatty liver disease (MAFLD) has become a prevalent chronic liver
disease worldwide because of lifestyle and dietary changes. Gut microbiota and its …

非酒精性脂肪性肝病(NAFLD) 在全球范围内患病率高达30%, 严重影响人类健康并构成公共
卫生负担. 由于该病难以诊断和监控, 因此, 识别潜在的药物靶点和生物标志物具有重要价值 …

The Retinoid X Receptor (RXR) is a member of the nuclear receptor superfamily and
regulates gene transcription as well as diverse cellular processes like metabolism …

The prevalence rate of nonalcoholic fatty liver disease (NAFLD) reaches up to 30% around
the world, and the disease has a serious impact on human health and constitutes a public …